Adjuvant chemotherapy for gastric cancer: Current evidence and future challenges

by Miceli, Rosalba, Tomasello, Gianluca, Bregni, Giacomo, Di Bartolomeo, Maria, Pietrantonio, Filippo
Published 2014

Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5- fluorouracil: a meta-analysis of published trials

by Iacovelli, Roberto, Pietrantonio, Filippo, Palazzo, Antonella, Maggi, Claudia, Ricchini, Francesca, de Braud, Filippo, Di Bartolomeo, Maria
Published in Br J Clin Pharmacol (2014)

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer

by Di Bartolomeo, Maria, Maggi, Claudia, Ricchini, Francesca, Pietrantonio, Filippo, Iacovelli, Roberto, de Braud, Filippo, Inno, Alessandro
Published in Clin Interv Aging (2015)

In Reply

by Baratti, Dario, Kusamura, Shigeki, Maggi, Claudia, de Braud, Filippo, Deraco, Marcello, Di Bartolomeo, Maria, Pietrantonio, Filippo
Published in Oncologist (2015)

Bax Expression Is Predictive of Favorable Clinical Outcome in Chemonaive Advanced Gastric Cancer Patients Treated with Capecitabine, Oxaliplatin, and Irinotecan Regimen

by Pietrantonio, Filippo, Biondani, Pamela, de Braud, Filippo, Pellegrinelli, Alessandro, Bianchini, Giampaolo, Perrone, Federica, Formisano, Barbara, Di Bartolomeo, Maria
Published 2012

Chemotherapy or Targeted Therapy as Second-Line Treatment of Advanced Gastric Cancer. A Systematic Review and Meta-Analysis of Published Studies

by Iacovelli, Roberto, Pietrantonio, Filippo, Farcomeni, Alessio, Maggi, Claudia, Palazzo, Antonella, Ricchini, Francesca, de Braud, Filippo, Di Bartolomeo, Maria
Published 2014

The Landscape of Actionable Gene Fusions in Colorectal Cancer

by Pagani, Filippo, Randon, Giovanni, Guarini, Vincenzo, Raimondi, Alessandra, Prisciandaro, Michele, Lobefaro, Riccardo, Di Bartolomeo, Maria, Sozzi, Gabriella, de Braud, Filippo, Gasparini, Patrizia, Pietrantonio, Filippo
Published in Int J Mol Sci (2019)

Role of MGMT as biomarker in colorectal cancer

by Inno, Alessandro, Fanetti, Giuseppe, Di Bartolomeo, Maria, Gori, Stefania, Maggi, Claudia, Cirillo, Massimo, Iacovelli, Roberto, Nichetti, Federico, Martinetti, Antonia, de Braud, Filippo, Bossi, Ilaria, Pietrantonio, Filippo
Published in World J Clin Cases (2014)

Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens

by Martinetti, Antonia, Miceli, Rosalba, Sottotetti, Elisa, Di Bartolomeo, Maria, de Braud, Filippo, Gevorgyan, Arpine, Dotti, Katia Fiorella, Bajetta, Emilio, Campiglio, Manuela, Bianchi, Francesca, Bregni, Giacomo, Pietrantonio, Filippo
Published 2014

Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status

by Pietrantonio, Filippo, Maggi, Claudia, Di Bartolomeo, Maria, Facciorusso, Maria Grazia, Perrone, Federica, Testi, Adele, Iacovelli, Roberto, Miceli, Rosalba, Bossi, Ilaria, Leone, Giorgia, Milione, Massimo, Pelosi, Giuseppe, de Braud, Filippo
Published 2014

Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis

by Petrelli, Fausto, Berenato, Rosa, Turati, Luca, Mennitto, Alessia, Steccanella, Francesca, Caporale, Marta, Dallera, Pierpaolo, de Braud, Filippo, Pezzica, Ezio, Di Bartolomeo, Maria, Sgroi, Giovanni, Mazzaferro, Vincenzo, Pietrantonio, Filippo, Barni, Sandro
Published in J Gastrointest Oncol (2017)

Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis

by Pusceddu, Sara, Ghidini, Michele, Torchio, Martina, Corti, Francesca, Tomasello, Gianluca, Niger, Monica, Prinzi, Natalie, Nichetti, Federico, Coinu, Andrea, Di Bartolomeo, Maria, Cabiddu, Mary, Passalacqua, Rodolfo, de Braud, Filippo, Petrelli, Fausto
Published in Cancers (Basel) (2019)

Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD‐L1 in Gastric Cancer Patients Treated with Either Adjuvant 5‐FU/LV or Sequential FOLFIRI...

by Di Bartolomeo, Maria, Morano, Federica, Raimondi, Alessandra, Miceli, Rosalba, Corallo, Salvatore, Tamborini, Elena, Perrone, Federica, Antista, Maria, Niger, Monica, Pellegrinelli, Alessandro, Randon, Giovanni, Pagani, Filippo, Martinetti, Antonia, Fucà, Giovanni, Pietrantonio, Filippo
Published in Oncologist (2019)

The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence

by Pusceddu, Sara, Vernieri, Claudio, Prinzi, Natalie, Torchio, Martina, Coppa, Jorgelina, Antista, Maria, Niger, Monica, Milione, Massimo, Giacomelli, Luca, Corti, Francesca, Prisciandaro, Michele, Monteleone, Michela, Colombo, Elena, Di Bartolomeo, Maria, de Braud, Filppo
Published in Therap Adv Gastroenterol (2020)

Role of cMET in the Development and Progression of Colorectal Cancer

by Pérez-Vargas, Juan Carlos Samamé, Biondani, Pamela, Maggi, Claudia, Gariboldi, Manuela, Gloghini, Annunziata, Inno, Alessandro, Volpi, Chiara Costanza, Gualeni, Ambra Vittoria, di Bartolomeo, Maria, de Braud, Filippo, Castano, Alessandra, Bossi, Ilaria, Pietrantonio, Filippo
Published 2013

Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell Carcinoma

by Torchio, Martina, Cattaneo, Laura, Milione, Massimo, Prinzi, Natalie, Corti, Francesca, Ungari, Marco, Anichini, Andrea, Mortarini, Roberta, Occhini, Antonio, Bertino, Giulia, Maurichi, Andrea, Coppa, Jorgelina, Di Bartolomeo, Maria, de Braud, Filippo Guglielmo, Pusceddu, Sara
Published in Front Oncol (2021)

Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase

by Falvella, Felicia Stefania, Caporale, Marta, Cheli, Stefania, Martinetti, Antonia, Berenato, Rosa, Maggi, Claudia, Niger, Monica, Ricchini, Francesca, Bossi, Ilaria, Di Bartolomeo, Maria, Sottotetti, Elisa, Bernardi, Francesca Futura, de Braud, Filippo, Clementi, Emilio, Pietrantonio, Filippo
Published in Int J Mol Sci (2015)

DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan

by Falvella, Felicia Stefania, Cheli, Stefania, Martinetti, Antonia, Mazzali, Cristina, Iacovelli, Roberto, Maggi, Claudia, Gariboldi, Manuela, Pierotti, Marco Alessandro, Di Bartolomeo, Maria, Sottotetti, Elisa, Mennitto, Roberta, Bossi, Ilaria, de Braud, Filippo, Clementi, Emilio, Pietrantonio, Filippo
Published in Br J Clin Pharmacol (2015)

One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches

by Niger, Monica, Prisciandaro, Michele, Antista, Maria, Monica, Melissa Anna Teresa, Cattaneo, Laura, Prinzi, Natalie, Manglaviti, Sara, Nichetti, Federico, Brambilla, Marta, Torchio, Martina, Corti, Francesca, Pusceddu, Sara, Coppa, Jorgelina, Mazzaferro, Vincenzo, de Braud, Filippo, Di Bartolomeo, Maria
Published in World J Gastrointest Oncol (2020)

Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens: Clinical outcome and biomarkers of efficacy

by Pietrantonio, Filippo, Perrone, Federica, Biondani, Pamela, Maggi, Claudia, Lampis, Andrea, Bertan, Claudia, Venturini, Filippo, Tondulli, Luca, Ferrari, Daris, Ricci, Vincenzo, Villa, Federica, Barone, Gloria, Bianco, Nadia, Ghidini, Antonio, Bossi, Ilaria, Fanetti, Giuseppe, Di Bartolomeo, Maria, de Braud, Filippo
Published 2013